Introducing Electronic Alerts to Reduce Inappropriate Digoxin Prescribing in Older Adults

NCT07008144 · tracked via the Priya Life Science Spain tracker

Sponsor

Consorci Sanitari de l'Alt Penedès i Garraf

Phase

Not applicable

Started

2025-12

Last updated

2025-12-02

Condition(s) studied

Drug-Related Side Effects and Adverse ReactionDigoxin Overdose

Investigational drug(s) / intervention(s)

Digoxin alarm

Digoxin alarm: A computerized alert will be integrated into the CSAPG electronic health record system (MIRA software). These alerts will be triggered when a physician prescribes digoxin at a dose higher than the recommended 0.125 mg/day for elderly patients.

Study summary

The intervention consists of introducing computerized alerts into the electronic medical record of the CSAPG (MIRA software), which are triggered when a physician prescribes digoxin at a dose higher than the recommended amount (more than 0.125 mg/day).

The main objective of this study is to evaluate the effectiveness of a visible computerized alert aimed at physicians responsible for hospitalized elderly patients who have been prescribed digoxin at a dose higher than 0.125 mg/day (the recommended dose), in reducing the number of patients receiving inappropriate digoxin doses.

Eligibility

Sex

ALL

Min age

65 Years

Max age

—

Healthy volunteers

Inclusion Criteria: * Men and women over 64 years of age. * Hospitalized in inpatient wards of the study centers during the study period. Exclusion Criteria: * Pacients under 64 years old * Patients without complete data available

Primary outcome measure(s)

Proportion of elderly inpatients receiving inappropriate digoxin doses — From baseline to hospital discharge, as much 3 months
Proportion of patients aged 65 and older who are prescribed digoxin at a dose higher than 0.125 mg/day during hospitalization. The outcome compares this proportion between the pre-intervention and post-intervention periods to evaluate the effectiveness of a computerized alert integrated into the electronic medical record system (MIRA).

Trial sites (2)

Facility	City	Region	Status
Consorci Sanitari Alt Penedès-Garraf-Hospital de Vilafranca	Vilafranca del Penedès	Barcelona
Consorci Sanitari Alt Penedès-Garraf Hospital Sant Camil	Barcelona	Spain

More Consorci Sanitari de l'Alt Penedès i Garraf trials in Spain

Impact of Humor Prescription on the Emotional Well-being of Patients With Medically Unexplained Symptoms: A Quasi-experimental Study Active, not recruiting

Predictive Model for Mortality in Older People With Critical Illness Recruiting

Tapping Test and the Archimedean Spiral for the Differential Diagnosis of Tremor. Machine Learning Approach Recruiting

Is a Positive NECPAL in ICU Patients Associated With Higher Mortality Recruiting

High-risk Antithrombotic Drugs at Discharge and Consultation for Hemorrhagic or Thromboembolic Events in the Emergency Department Starting soon

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07008144 on ClinicalTrials.gov ↗ ← All trials in Spain